BJDX

Bluejay Diagnostics, Inc. (BJDX) SWOT Analysis Analysis (2026)

Invetso Score: 2.4/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 2.1 (Weak)

The negative cash conversion cycle suggests working-capital efficiency versus peers, but the extreme magnitude likely reflects reporting mechanics rather than durable operating superiority.

Debt-to-equity is very low, indicating limited balance-sheet leverage versus more indebted peers, although this does not offset weak underlying profitability.

Current and quick ratios are both 4.6x, implying ample short-term liquidity versus peers and reducing near-term funding pressure.

The reported cash conversion profile can support liquidity management, but the absence of positive margin data leaves no evidence of durable competitive advantage.

Weaknesses

Score:

Return on invested capital is deeply negative, showing capital destruction versus peers and indicating the business is not converting invested funds into economic returns.

No operating or gross margin disclosure in the provided metrics prevents evidence of pricing power, while peers with positive margins likely have structurally stronger economics.

Net debt to EBITDA is elevated at 1.33x despite low equity leverage, implying earnings capacity remains weak relative to peers with stronger cash generation.

The combination of negative ROIC and limited profitability evidence suggests the company trails peers on core operating efficiency and long-term value creation.

Opportunities

Score:

If management improves unit economics, the current liquidity cushion provides room to stabilize operations faster than more constrained peers.

A low debt burden could support restructuring or reinvestment flexibility, creating more optionality than peers with tighter balance sheets.

The unusually negative cash conversion cycle may reflect working-capital release potential, which could improve cash generation if normalized versus peers.

Absent segment and growth data, the main opportunity is operational repair rather than market-share expansion, leaving upside less visible than for stronger peers.

Threats

Score:

Persistent negative ROIC threatens long-term competitiveness because peers with positive returns can compound capital while this business destroys it.

Elevated net debt to EBITDA can become more restrictive if earnings remain weak, especially versus peers with stronger leverage capacity.

Without margin evidence, the company appears more exposed to pricing pressure and cost inflation than peers with proven operating leverage.

The lack of disclosed growth and segment concentration data limits visibility, but peers with diversified or faster-growing businesses likely face less structural fragility.

Overall Score

Score:

BJDX screens as structurally weak versus peers because deeply negative ROIC outweighs its liquidity and low equity leverage, leaving limited evidence of durable competitive strength.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Bluejay Diagnostics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →